PL

Peter Lange

Co-Founder & CEO

Reven Pharmaceuticals

Reven Pharmaceuticals Pipeline

DrugIndicationPhase
RJXCOVID-19 ARDS and SepsisPhase 1/2
RJX PlatformVascular, Oncology, CNS, Ocular DiseasesResearch/Preclinical